Financial Gravity Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-110
| Closed | -$275 | – | 1744 |
|
|
2024
Q1 | $275 | Buy |
110
+78
| +244% | +$195 | ﹤0.01% | 1553 |
|
|
2023
Q4 | $72 | Buy |
32
+16
| +100% | +$36 | ﹤0.01% | 1292 |
|
|
2023
Q3 | $33 | Buy |
16
+9
| +129% | +$19 | ﹤0.01% | 1080 |
|
|
2023
Q2 | $107 | Sell |
7
-3
| -30% | -$46 | ﹤0.01% | 1290 |
|
|
2023
Q1 | $171 | Sell |
10
-2
| -17% | -$34 | 0.01% | 646 |
|
|
2022
Q4 | $198 | Sell |
12
-240
| -95% | -$3.96K | ﹤0.01% | 946 |
|
|
2022
Q3 | $346 | Sell |
252
-120
| -32% | -$165 | 0.01% | 449 |
|
|
2022
Q2 | $513 | Sell |
372
-120
| -24% | -$165 | 0.02% | 388 |
|
|
2022
Q1 | $679 | Sell |
492
-67
| -12% | -$92 | 0.02% | 371 |
|
|
2021
Q4 | $725 | Buy |
559
+542
| +3,188% | +$703 | 0.02% | 429 |
|
|
2021
Q3 | $50K | Hold |
17
| – | – | 0.02% | 569 |
|
|
2021
Q2 | $63K | Sell |
17
-35
| -67% | -$130K | 0.02% | 489 |
|
|
2021
Q1 | $4.85K | Sell |
52
-54
| -51% | -$5.03K | 0.1% | 148 |
|
|
2020
Q4 | $9K | Buy |
+106
| New | +$9K | 0.01% | 186 |
|
|
2020
Q2 | – | Sell |
-1,068
| Closed | -$61.7K | – | 246 |
|
|
2020
Q1 | $61.7K | Sell |
1,068
-447
| -30% | -$25.8K | 0.19% | 61 |
|
|
2019
Q4 | $54K | Sell |
1,515
-746
| -33% | -$26.6K | 0.04% | 600 |
|
|
2019
Q3 | $118K | Sell |
2,261
-504
| -18% | -$26.3K | 0.1% | 182 |
|
|
2019
Q2 | $134K | Sell |
2,765
-593
| -18% | -$28.7K | 0.11% | 194 |
|
|
2019
Q1 | $169K | Buy |
+3,358
| New | +$169K | 0.14% | 153 |
|
|
2018
Q3 | $192K | Sell |
3,246
-148
| -4% | -$8.75K | 0.2% | 127 |
|
|
2018
Q2 | $187K | Sell |
3,394
-325
| -9% | -$17.9K | 0.18% | 137 |
|
|
2018
Q1 | $190K | Buy |
+3,719
| New | +$190K | 0.19% | 104 |
|